How a new drug reacts with food and other medicines in healthy women
Treatments studied
This trial checks how a new experimental drug (called Navlimetostat) interacts with other medicines and how food affects it. Healthy women participate to help researchers find the right dose and safety, which could later help people with cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult female (born female) and not able to have children (like after menopause or a hysterectomy).
- Your body mass index (BMI) must be between 18 and 35.
- You must not have any serious short-term or long-term medical conditions.
- You must not have a history of prolonged bleeding or easy bruising.
- You must not have any known or suspected immune system problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety study testing a new tablet form of navlimetostat in healthy adult women. The goal is to understand how the body processes this drug and make sure it is safe and well-tolerated.
This study looks at how the experimental drug navlimetostat is processed and removed from the body in healthy women. It helps researchers understand the drug's effects before it is tested in patients.
This study checks if stomach acid medicine and another drug affect how the body handles a new investigational drug. It helps researchers understand dosing for future patients.
This study checks if a new oral drug, MDR-001, interacts safely with two common medicines (rifampin and itraconazole) when taken together. It's for healthy volunteers, and the results will help guide dosing for future patients.
This study tests a new drug (clifutinib) in healthy volunteers to see how other common medicines (itraconazole, fluconazole, and efavirenz) affect its levels in the body. The results will help doctors understand how to dose clifutinib in future patients.
This study is testing whether a common antifungal drug (itraconazole) affects how the body processes a new experimental medicine (HS-10506). The goal is to see if the two drugs can be used together safely.
Hear when a new Healthy Female Adults trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.